Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey C Stevens

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|April 26, 2006
New perspectives on the impact of cytochrome P450 3A expression for pediatric pharmacologyJeffrey C Stevens
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 13, 2018
EditorialJeffrey C Stevens
Combinatorial Chemistry & High Throughput Screening|January 8, 2010
Evaluation of drug transporter interactions in drug discovery and developmentYurong Lai, Kathleen E Sampson, Jeffrey C Stevens
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 29, 2014
Mass cytometry: a highly multiplexed single-cell technology for advancing drug developmentKondala R Atkuri, Jeffrey C Stevens, Hendrik Neubert
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearanceDaniel C Kemp, Peter W Fan, Jeffrey C Stevens
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2006
Epirubicin glucuronidation and UGT2B7 developmental expressionMatthew J Zaya, Ronald N Hines, Jeffrey C Stevens
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2002
Mechanism-based inactivation of cytochrome P450 2B6 by a novel terminal acetylene inhibitorPeter W Fan, Chungang Gu, Sandra A Marsh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 19, 2003
The changing environment of graduate and postdoctoral training in drug metabolism: viewpoints from academia, industry, and governmentJeffrey C Stevens, Dennis C Dean, Peter C Preusch, et al.
Molecular Pharmacology|January 16, 2003
Expression and characterization of functional dog flavin-containing monooxygenase 1Jeffrey C Stevens, Roger J Melton, Matthew J Zaya, et al.
Biochemical Pharmacology|May 26, 2009
Human hepatic CYP2B6 developmental expression: the impact of age and genotypeEdward L Croom, Jeffrey C Stevens, Ronald N Hines, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|April 26, 2006
New perspectives on the impact of cytochrome P450 3A expression for pediatric pharmacologyJeffrey C Stevens
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 13, 2018
EditorialJeffrey C Stevens
Combinatorial Chemistry & High Throughput Screening|January 8, 2010
Evaluation of drug transporter interactions in drug discovery and developmentYurong Lai, Kathleen E Sampson, Jeffrey C Stevens
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 29, 2014
Mass cytometry: a highly multiplexed single-cell technology for advancing drug developmentKondala R Atkuri, Jeffrey C Stevens, Hendrik Neubert
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearanceDaniel C Kemp, Peter W Fan, Jeffrey C Stevens
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2006
Epirubicin glucuronidation and UGT2B7 developmental expressionMatthew J Zaya, Ronald N Hines, Jeffrey C Stevens
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2002
Mechanism-based inactivation of cytochrome P450 2B6 by a novel terminal acetylene inhibitorPeter W Fan, Chungang Gu, Sandra A Marsh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 19, 2003
The changing environment of graduate and postdoctoral training in drug metabolism: viewpoints from academia, industry, and governmentJeffrey C Stevens, Dennis C Dean, Peter C Preusch, et al.
Molecular Pharmacology|January 16, 2003
Expression and characterization of functional dog flavin-containing monooxygenase 1Jeffrey C Stevens, Roger J Melton, Matthew J Zaya, et al.
Biochemical Pharmacology|May 26, 2009
Human hepatic CYP2B6 developmental expression: the impact of age and genotypeEdward L Croom, Jeffrey C Stevens, Ronald N Hines, et al.
Pageof 2